HIV attachment inhibitor BMS-663068 safe and effective in phase 2b study
Deferring hepatitis C treatment can lead to liver cancer and death, despite cure
Progression to severe fibrosis or cirrhosis is common among baby boomers with hepatitis C in the US
Study finds high rates of cancer among older people living with HIV
Levels of maraviroc in vaginal and rectal tissues may not be high enough for pre-exposure prophylaxis
Financial incentives did not improve linkage to care or viral suppression in US study
Tenofovir, boosted atazanavir and boosted lopinavir are associated with cumulative risk of developing chronic kidney disease
Two interferon-free regimens show high HCV cure rates for people with HIV and HCV co-infection
Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation
